Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review

Platinum-based chemotherapy has been the standard of care for ovarian cancer for the past 3 decades. Although most patients respond to platinum-based treatment, emergence of platinum resistance in recurrent ovarian cancer is inevitable during the disease course. Outcomes for patients with platinum-r...

Full description

Bibliographic Details

Published in:	JAMA oncology Vol. 9; no. 6; p. 851
Main Authors:	Richardson, Debra L, Eskander, Ramez N, O'Malley, David M
Format:	Journal Article
Language:	English
Published:	United States 01.06.2023
Subjects:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - therapeutic use Carcinoma, Ovarian Epithelial - drug therapy Female Humans Neoplasm Recurrence, Local - drug therapy Ovarian Neoplasms - drug therapy Platinum - therapeutic use
ISSN:	2374-2445, 2374-2445
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!